Pestel and Tony C. have been on the team already, and when it was their turn at bat, they were't even able to find their way out of the locker room. Nader P. is up at bat now and he may connect, or he may strike out, but I like that he swings hard and always for the fences! The only thing I know for sure is he won't sell us out.

I'm not surprised by this 5% move at all. Share price manipulation and disrupting management is right out of the big pharma buyout playbook. They are likely manipulating the shareholders to revolt. In my opinion, our lack of approval from the FDA has a lot more to do with the 11 out of 19 members of the Covid Task Force that have financial ties to Gilead, than it does to Nader P. There aren't enough patients in the US to continue the trials here. Pivoting overseas is a good move that will hopefully pay off. Our Brazil trials should be about mid-way if and when the next wave hits the US.

The Indian variants are on the rise, overtaking the UK variant. Meanwhile, the U.S. is weakening the mask mandate and letting our guard down, with less than half of the population vaccinated. It's almost as if they are looking for more Remdesivir patients? If we are hit hard with yet another Covid-19 wave, I hope that Fauci and friends are thrown out. Now that's a coup I can get behind!